Etiology of epithelial ovarian cancer: a cellular mechanism for the role of gonadotropins

By Smith E.R.   Xu X.-X.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

IGF-II promoter methylation and ovarian cancer prognosis

By Beeghly A.   Katsaros D.   Wiley A.   Rigault de la Longrais I.   Prescott A.   Chen H.   Puopolo M.   Rutherford T.   Yu H.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 713-723

Springer Publishing Company

Access to resources Recommend Favorite

DNA Methylation in Ovarian Cancer - II. Expression of DNA Methyltransferases in Ovarian Cancer Cell Lines and Normal Ovarian Epithelial Cells

By Ahluwalia A.   Hurteau J.A.   Bigsby R.M.   Nephew K.P.  

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite

A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer

By                            

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 657-663

Spandidos Publications

Access to resources Recommend Favorite

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells

By Kanamori Y.   Kigawa J.   Minagawa Y.   Irie T.   Oishi T.   Shimada M.   Takahashi M.   Nakamura T.   Sato K.   Terakawa N.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1802-1806

Elsevier

Access to resources Recommend Favorite